Literature DB >> 1387764

DNA-testing for Huntington's disease in The Netherlands: a retrospective study on psychosocial effects.

A Tibben1, M Vegter-van der Vlis, M I Skraastad, P G Frets, J J van der Kamp, M F Niermeijer, G J van Ommen, R A Roos, H G Rooijmans, D Stronks.   

Abstract

Presymptomatic DNA-testing for Huntington's disease has made it possible to predict whether or not at-risk individuals are gene-carriers with a reliability of about 98%. In our retrospective study of 18 tested individuals, most of the newly identified carriers function apparently well. They use avoidance and repression of affect as psychological defense strategies. However, 8 out of 9 non-carriers do not experience the expected relief about their test results. They experience survivor guilt and emotional numbness and find it difficult to cope with the effects of the test results on the family system. The partners of gene-carriers are at risk of becoming emotionally isolated by putting aside their own feelings for fear of seeming self-centered. Appreciation of these effects on tested individuals is important and professional support is needed to prevent post-traumatic stress disorders. Whatever the test result may be, the working through process may take years rather than months. These findings have important implications for patient care and necessitate an extended period of observation after presymptomatic testing.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1387764     DOI: 10.1002/ajmg.1320440122

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

1.  Evaluation of a counselling protocol for predictive genetic testing for hereditary non-polyposis colorectal cancer.

Authors:  K Aktan-Collan; J P Mecklin; A de la Chapelle; P Peltomäki; A Uutela; H Kääriäinen
Journal:  J Med Genet       Date:  2000-02       Impact factor: 6.318

2.  Interpersonal responses among sibling dyads tested for BRCA1/BRCA2 gene mutations.

Authors:  Heidi A Hamann; Timothy W Smith; Ken R Smith; Robert T Croyle; John M Ruiz; John C Kircher; Jeffrey R Botkin
Journal:  Health Psychol       Date:  2008-01       Impact factor: 4.267

3.  Presymptomatic testing for neurogenetic diseases in Brazil: assessing who seeks and who follows through with testing.

Authors:  Caroline Santa Maria Rodrigues; Viviane Ziebell de Oliveira; Gabriela Camargo; Claudio Maria da Silva Osório; Raphael Machado de Castilhos; Maria Luiza Saraiva-Pereira; Lavínia Schuler-Faccini; Laura Bannach Jardim
Journal:  J Genet Couns       Date:  2011-06-30       Impact factor: 2.537

4.  Psychological follow-up of presymptomatic genetic testing for spinocerebellar ataxia type 2 (SCA2) in Cuba.

Authors:  Milena Paneque; Carolina Lemos; Karell Escalona; Lizandra Prieto; Rubén Reynaldo; Mercedes Velázquez; Judith Quevedo; Nieves Santos; Luis Enrique Almaguer; Luis Velázquez; Alda Sousa; Manuela Fleming; Jorge Sequeiros
Journal:  J Genet Couns       Date:  2007-02-23       Impact factor: 2.537

Review 5.  Familial melanoma: a complex disorder leading to controversy on DNA testing.

Authors:  Femke A de Snoo; Wilma Bergman; Nelleke A Gruis
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

6.  First experiences with genetic counselling based on predictive DNA diagnosis in hereditary glomus tumours (paragangliomas).

Authors:  J C Oosterwijk; J C Jansen; E M van Schothorst; A W Oosterhof; P Devilee; E Bakker; M W Zoeteweij; A G van der Mey
Journal:  J Med Genet       Date:  1996-05       Impact factor: 6.318

Review 7.  Huntington's disease: pathogenesis, diagnosis and treatment.

Authors:  S E Purdon; E Mohr; V Ilivitsky; B D Jones
Journal:  J Psychiatry Neurosci       Date:  1994-11       Impact factor: 6.186

8.  Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group.

Authors:  T M Wagner; R Möslinger; G Langbauer; R Ahner; E Fleischmann; A Auterith; A Friedmann; T Helbich; C Zielinski; E Pittermann; M Seifert; P Oefner
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

9.  The Clinical and Psychosocial Outcomes for Women Who Received Unexpected Clinically Actionable Germline Information Identified through Research: An Exploratory Sequential Mixed-Methods Comparative Study.

Authors:  Laura E Forrest; Rowan Forbes Shepherd; Erin Tutty; Angela Pearce; Ian Campbell; Lisa Devereux; Alison H Trainer; Paul A James; Mary-Anne Young
Journal:  J Pers Med       Date:  2022-07-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.